Bone marrow niches orchestrate stem-cell hierarchy and immune tolerance.

骨髓微环境调控干细胞层级和免疫耐受

阅读:9
作者:Furuhashi Kazuhiro, Kakiuchi Miwako, Ueda Ryosuke, Oda Hiroko, Ummarino Simone, Ebralidze Alexander K, Bassal Mahmoud A, Meng Chen, Sato Tatsuyuki, Lyu Jing, Han Min-Guk, Maruyama Shoichi, Watanabe Yu, Sawa Yuriko, Kato Daisuke, Wake Hiroaki, Reizis Boris, Frangos John A, Owens David M, Tenen Daniel G, Ghiran Ionita C, Robson Simon C, Fujisaki Joji
Stem cells reside in specialized microenvironments, termed niches, at several different locations in tissues(1-3). The differential functions of heterogeneous stem cells and niches are important given the increasing clinical applications of stem-cell transplantation and immunotherapy. Whether hierarchical structures among stem cells at distinct niches exist and further control aspects of immune tolerance is unknown. Here we describe previously unknown new hierarchical arrangements in haematopoietic stem cells (HSCs) and bone marrow niches that dictate both regenerative potential and immune privilege. High-level nitric oxide-generating (NO(hi)) HSCs are refractory to immune attack and exhibit delayed albeit robust long-term reconstitution. Such highly immune-privileged, primitive NO(hi) HSCs co-localize with distinctive capillaries characterized by primary ciliated endothelium and high levels of the immune-checkpoint molecule CD200. These capillaries regulate the regenerative functions of NO(hi) HSCs through the ciliary protein IFT20 together with CD200, endothelial nitric oxide synthase and autophagy signals, which further mediate immunoprotection. Notably, previously described niche constituents, sinusoidal cells and type-H vessels(2-10) co-localize with less immune-privileged and less potent NO(low) HSCs. Together, we identify highly immune-privileged, late-rising primitive HSCs and characterize their immunoprotective niches comprising specialized vascular domains. Our results indicate that the niche orchestrates hierarchy in stem cells and immune tolerance, and highlight future immunotherapeutic targets.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。